Nomenclature - Granulocyte immunology - Chapter 17
The current HNA nomenclature is based on epitopes and allelic typing and this must be used for recording granulocyte-specific alloantigen and alloantibody specificities [Flesch, 2016]. Details of nomenclature for HNA alleles, epitopes and corresponding antibodies are shown in Tables 17.1.1 to 17.1.5.
Allele | Epitopes | Original name | Glycoprotein | CD |
---|---|---|---|---|
FCGR3B*01 |
HNA-1a |
NA1 |
FcγRIIIb |
CD16 |
FCGR3B*02 |
HNA-1b, HNA-1d |
NA2 |
FcγRIIIb |
CD16 |
FCGR3B*03 |
HNA-1b, HNA-1c |
SH |
FcγRIIIb |
CD16 |
FCGR3B*04 |
HNA-1a |
n/a |
FcγRIIIb |
CD16 |
FCGR3B*05 |
HNA-1bv (†) |
n/a |
FcγRIIIb |
CD16 |
Notes on Table 17.1.1
(†) ‘v’ indicates a variant epitope that may have different serological characteristics with some antisera.
Allele | Epitopes | Original name | Glycoprotein | CD |
---|---|---|---|---|
Unknown |
HNA-2 |
NB1 |
GP56-64kDa |
CD177 |
Allele | Epitopes | Original name | Glycoprotein | CD |
---|---|---|---|---|
SLC44A2*01 |
HNA-3a |
5b |
CTL-2 |
n/a |
SLC44A2*02 |
HNA-3b |
5a |
CTL-2 |
n/a |
SLC44A2*03 |
HNA-3av (†) |
n/a |
CTL-2 |
n/a |
Notes on Table 17.1.3
(†) ‘v’ indicates a variant epitope that may have different serological characteristics with some antisera.
Allele | Epitopes | Original name | Glycoprotein | CD |
---|---|---|---|---|
ITGAM*01 |
HNA-4a |
MARTa |
CD11/18 |
CD11b |
ITGAM*02 |
HNA-4bw (†) |
n/a |
CD11/18 |
CD11b |
Notes on Table 17.1.4
(†) ‘w’ indicates a workshop designation – no antibodies against this epitope have currently been described.
Allele | Epitopes | Original name | Glycoprotein | CD |
---|---|---|---|---|
ITGAL*01 |
HNA-5a |
ONDa |
CD11/18 |
CD11a |
ITGAL*01 |
HNA-5bw (†) |
n/a |
CD11/18 |
CD11a |
Notes on Table 17.1.5
(†) ‘w’ indicates a workshop designation – no antibodies against this epitope have currently been described.
References
Flesch BK, Curtis BR, de Haas M, Lucas G, Sachs UJ (2016). Update on the nomenclature of human neutrophil antigens and alleles. Transfusion, 56, 1477–1479.